Apellis Pharmaceuticals Stock (NASDAQ: APLS) stock price, news, charts, stock research, profile.
You can purchase shares of Apellis Pharmaceuticals (NASDAQ:APLS) through any online brokerage.
There are no as such competitors for Apellis Pharmaceuticals.
Apellis Pharmaceuticals has a consensus price target of $50.79.
The stock price for Apellis Pharmaceuticals (NASDAQ: APLS) is $30.39 last updated January 30, 2025 at 4:00 PM EST.
There are no upcoming dividends for Apellis Pharmaceuticals.
Apellis Pharmaceuticals’s Q4 earnings are confirmed for Tuesday, February 25, 2025.
There is no upcoming split for Apellis Pharmaceuticals.
Apellis Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.